Medicaid/CHIP surveillance demonstrated an 11.4% relative rise in pediatric diabetes prevalence, including a 24.3% increase in type 2 diabetes, with disparities by geography, sex, and region.
A home blood pressure telemonitoring program effectively reduced blood pressure in real-world clinical settings, but program enrollment expenses increased overall costs.
Using nationally representative data, the authors found that for common physician-administered drugs, hospitals’ unilaterally set cash prices are frequently lower than their median—and sometimes even ...
Community programs like Go for Bold improve health, but lasting, equitable gains require complementary structural food policies—including taxes, reformulation, and labeling—to shift environments and ...
Total RHTP allocations varied widely ($147M–$281M) and did not track state rural population size, yielding extreme per–rural-resident differences across baseline and variable components. Higher ...
A home blood pressure telemonitoring (HBPT) program effectively reduced BP in real-world clinical settings, but its enrollment expenses increased overall costs. The HBPT program reduced BP clinic ...
Noah Greenspan, DPT explains challenges diagnosing long COVID and strategies like pacing, compression, and electrolytes to support recovery. Long COVID has been an ongoing health concern in the United ...
Community programs like Go for Bold improve health, but lasting, equitable gains require complementary structural food policies—including taxes, reformulation, and labeling—to shift environments and ...
Clinicians must consider patient comorbidities and therapy safety when selecting immunotherapy for cSCC, says Todd ...
A home blood pressure telemonitoring program effectively reduced blood pressure in real-world clinical settings, but program enrollment expenses increased overall costs. 259 Prospect Plains Rd, Bldg H ...
At the Winter Clinical Dermatology Meeting, April W. Armstrong, MD, MPH, professor and chief of dermatology at the UCLA ...
Regulatory expansion positions deucravacitinib 6 mg once daily as a first-in-class oral TYK2 option for active PsA, complementing its prior plaque psoriasis indication. POETYK PsA-1 showed significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results